Smoking cessation services in U.S. methadone maintenance facilities

scientific article published in November 2004

Smoking cessation services in U.S. methadone maintenance facilities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1176/APPI.PS.55.11.1258
P698PubMed publication ID15534014
P5875ResearchGate publication ID8186934

P50authorJasjit AhluwaliaQ60055425
P2093author name stringWon S Choi
Robert M McCool
Kimber P Richter
Kari J Harris
P433issue11
P304page(s)1258-1264
P577publication date2004-11-01
P1433published inPsychiatric ServicesQ7256227
P1476titleSmoking cessation services in U.S. methadone maintenance facilities
P478volume55

Reverse relations

cites work (P2860)
Q36642474A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment
Q47606772A cross-sectional analysis of factors associated with the intention to engage in tobacco treatment among inpatients in a state psychiatric hospital.
Q36912594A quasi-experimental study examining New York State's tobacco-free regulation: effects on clinical practice behaviors.
Q35017325A rationale and model for addressing tobacco dependence in substance abuse treatment
Q89928410Achieving Smoking Cessation Among Persons with Opioid Use Disorder
Q35909531Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings.
Q33629806Addressing tobacco in Australian alcohol and other drug treatment settings: a cross-sectional survey of staff attitudes and perceived barriers
Q33781918Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas
Q49314015Alcohol and tobacco use among methadone maintenance patients in Vietnamese rural mountainside areas.
Q37187104An international systematic review of smoking prevalence in addiction treatment
Q35147373Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation
Q35975307Barriers to Telephone Quitline Use Among Methadone-Maintained Smokers
Q30202808Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services
Q87259101Capacity of US drug treatment facilities to provide evidence-based tobacco treatment
Q37341497Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities
Q35553975Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study
Q37373872Cigarette smoking among opioid-dependent clients in a therapeutic community
Q36946388Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States
Q37619870Climate for innovation, 12-step orientation, and tobacco cessation treatment
Q37011843Commentary on Szatkowski & McNeill (2013): Where the smokers are.
Q40451688Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities.
Q89149140Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States
Q35092020Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients
Q37250251Correlates of heavy smoking among alcohol-using methadone maintenance clients
Q37632330Counselor and clinical supervisor perceptions of OASAS tobacco-free regulation implementation extensiveness, perceived accountability, and use of resources
Q36283095Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment
Q34066720Development of the Smoking Knowledge, Attitudes, and Practices (S-KAP) Instrument
Q34967022Differences in Substance Abuse Counselors' Knowledge of Tobacco Cessation Medication Effectiveness: 2002-2008.
Q91624743Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment
Q34111054Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations
Q38674919Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam
Q37072555Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education
Q36460342Going tobacco-free: predictors of clinician reactions and outcomes of the NY State Office of Alcoholism and Substance Abuse Services tobacco-free regulation
Q35570838How is tobacco treatment provided during drug treatment?
Q38868326Implementation of smoking cessation treatment in substance use disorder treatment settings: a review
Q37145902Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness
Q35417708Marijuana use and tobacco smoking cessation among heavy alcohol drinkers
Q34709097Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment
Q33984533Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study
Q58131549Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders
Q42860392Nicotine dependence and depression among women smokers on methadone maintenance
Q37724929Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.
Q36496900Predictors of dropout from group therapy among patients with bipolar and substance use disorders
Q34778712Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States
Q36291920Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study
Q34528070Smoking Cessation Services in Adolescent Substance Abuse Treatment: Opportunities Missed?
Q34334331Smoking among adolescents in substance abuse treatment: a study of programs, policy, and prevalence
Q37159031Smoking and opioid detoxification: behavioral changes and response to treatment.
Q48022741Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action
Q33923700Smoking cessation treatment among office-based buprenorphine treatment patients
Q35012377Smoking prevalence in addiction treatment: a review
Q33967949Staff Knowledge, Attitudes, and Practices Regarding Nicotine Dependence Differ by Setting
Q34267724Staff commitment to providing tobacco dependence in drug treatment: Reliability, validity, and results of a national survey
Q34357565Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review
Q34070104Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations
Q34245034Substance Abuse Treatment Counselors and Tobacco Use: A Comparison of Comprehensive and Indoor-Only Workplace Smoking Bans
Q36966583Substance abuse counselors' implementation of tobacco cessation guidelines
Q36823244Sustainment of smoking cessation programs in substance use disorder treatment organizations
Q52300494The New York policy on smoking in addiction treatment: findings after 1 year.
Q88551439The Untreated Addiction: Going Tobacco-Free in a VA Substance Abuse Residential Rehabilitation Treatment Program (SARRTP)
Q35291386The implementation of smoking cessation counseling in substance abuse treatment
Q33830328The implementation of tobacco-related brief interventions in substance abuse treatment: a national study of counselors
Q36992541The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities
Q30412259Understanding the drug treatment community's ambivalence towards tobacco use and treatment
Q34992065Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

Search more.